Genia Turanova, Chief Investment Strategist for Game-Changing Stocks and Fast-Track Millionaire, is a financial writer and money manager whose experience includes serving for more than a decade as a portfolio manager and Investment Committee member for a New York-based money management firm. Genia also researched, wrote and managed recommendations for several investment advisories. From 2011 to 2016, she served as Editor of the award-winning Leeb Income Performance newsletter. Genia also wrote for The Complete Investor, another award winner, from 2003 to 2016. During that time, Genia was responsible for several portfolios, including the "Income/Value" portfolio and the "FastTrack" portfolio. Genia's academic credentials include an MBA in Finance and Investments from the Zicklin School of Business, Baruch College in New York City. Genia is a CFA Charterholder.
Analyst Articles
One of the goals I have in mind when screening for stocks is to find fresh investment ideas —...
Read More
One of the goals I have in mind when screening for stocks is to find fresh investment ideas — ideas that have not been preconceived or predetermined by an analyst’s current thinking and...
Read More
It’s hard to underestimate the importance of understanding business and financial trends for...
Read More
It’s hard to underestimate the importance of understanding business and financial trends for successful investing. After all, it’s hard to be an effective investor if all you watch are...
Read More
As you know, small stocks can be quite volatile. They often have only one product or prospective product, and when that product or service is questioned, so is the share-price of the small company. This is what happened in the final hours of trading today,… Read More
I’m seeing less opportunity in Nektar (Nasdaq: NKTR), our “Opportunity Trade,” than I did as recently as Wednesday (see my Opportunity Trade update here). Here’s why: News from the company’s fourth-quarter conference call last night that the U.S. Food and Drug Administration (FDA) is… Read More
Security innovator Zscaler (Nasdaq: ZS) established a new high of $60 per share in early trading today, up more than 20%, after reporting better-than-expected quarterly results after Thursday’s close. For our portfolio, that translates to a gain of about 55% in less than eight months. Read More
One of the goals of my stock-screen feature is to find fresh investment ideas. Ideas that have not been preconceived or predetermined by an analyst’s current thinking and market outlook. These screens also generate new and sometimes unexpected ideas for my readers to consider. Read More
Shares of cyber-security company Mimecast (Nasdaq: MIME) shot up about 20% on February 12,...
Read More
Shares of cyber-security company Mimecast (Nasdaq: MIME) shot up about 20% on February 12, establishing a new all-time high in the process. The catalyst: a third-quarter earnings report that showed...
Read More
Two stocks from our Game-Changing Stocks portfolio are moving this morning, albeit in opposite directions. Medical equipment company Inogen (Nasdaq: INGN) is trading sharply lower this morning following a strong quarter (the company beat revenue and earnings expectations in the just-reported fourth quarter), and despite… Read More
Palo Alto Networks (NYSE: PANW), a security software company, rallied 8% this morning after releasing strong second-quarter 2019 results for the three months ended January 31, reported after Tuesday’s close. Revenue grew 30% year-over-year to $711 million. Better yet, PANW’s non-GAAP earnings jumped by… Read More
Investing is a hard business. You can’t take anything for granted, and there is no easy and fast formula to predict how well a stock will do. It’s hard to determine whether a company — even a leader… Read More
